Abstract
Gastrointestinal irritation is the most frequent adverse effect in patients chronically taking nonsteroidal antiinflammatory drugs (NSAIDs) for the treatment of arthritic conditions. Gastroprotective effect of DA-9601, a new antiulcer agent fromArtemisiae Herba extract, against NSAID was evaluated in a rat model of arthritis that is similar in many aspects to human rheumatoid arthritis. Daily oral dosing of naproxen (30 mg/kg), one of the most commonly used NSAID, induced apparent gastric lesions as well as a significant decrease in mucosal prostaglandin E2 (PGE2) and prostaglandin F1α (PGF1α) levels. Coadministration of DA-9601 prevents naproxen-induced mucosal injury and depletion, of prostaglandins, in a dose-related manner. DA-9601 did not alter the antiinflammatory or analgesic effect of naproxen. The present results suggest that DA-9601 may be useful as a mucoprotectant against NSAIDs in clinical practice.
Similar content being viewed by others
References Cited
Agrawal, N. M., Roth, S., Graham, D. Y., White, R. H., Germain, B., Brown, J. A. and Stromatt, S. C., Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer.Ann. Intern. Med., 115, 195–200 (1991).
Ballinger, A., Cytoprotection with misoprostol: use in the treatment and prevention of ulcers.Dig. Dis., 12, 37–45 (1994).
Baskin, W. N., Ivey, K. J., Krause, W. J., Jeffrey, G. E., and Gemmell, R. T., Aspirin induced ultrastructural changes in human gastric mucosa.Ann. Intern. Med., 85, 299–303 (1976).
Bradley, J. D., Brandt, K. D., Katz, B. P., Kalasinski, L. A. and Ryan, S. I., Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee.New Engl. J. Med., 325, 87–91 (1991).
Capetola, R. J., Shriver, D. A. and Rosenthale, M. E., Suprofen, a new peripheral analgesic.J. Pharm. Exp. Ther., 214, 16–23 (1980).
Caruso, J. and Porro, G. B., Gastroscopic evaluation of antiinflammatory agents.Br. Med. J., 280, 75–78 (1980).
Cho, C. H. and Ogle, C. W., Potentiation of indomethacin-induced gastric ulcers in rats by nordihydroguaiaretic acid (NDGA), an inhibitor of lipoxygenase.Asia Pacific J. Pharmacol., 2, 49–52 (1987).
Fenn, G. C. and Robinson, G. C., Misoprostol: a logical therapeutic approach to gastroduodenal mucosal injury induced by non-steroidal anti-inflammatory drugs.J. Clin. Pharm. Ther., 16, 385–409 (1991).
Fries, J. F., Miller, S. R., Spitz, B. W., Williams, C. A., Hubert, H. B. and Bloch, D. A., Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.Gastroenterology, 96, 647–655 (1989).
Gabriel, S. E., Jaakkimainen, L. and Bombardier, C., Risk for serious gastrointestinal complications related use of nonsteroidal anti-inflammatory drugs: a meta-analysis.Ann. Intern. Med., 115, 787–796 (1991).
Graham, D. Y., Prevention of gastroduodenal injury induced by chronic nonsteroidal antiinflammatory drug therapy.Gastroenterology, 96, 675–681 (1989).
Graham, D. Y., Agrawal, N. M., Roth, S. H., Prevention of NSAID-induced gastric ulcer with misoprostol: Multicentre, double blind, placebo-controlled trial.Lancet, ii, 1277–1280 (1988).
Graham, D. Y., White, R. H., Moreland, L. W., Schubert, T. T., Katz, R., Jaszewski, R., Tindall, E., Triadafilopoulos, G., Stromatt, S. C. and Teoh, L. S., Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs.Ann. Intern. Med., 119, 257–262 (1993).
Hawkey, C. J. and Rampton, D. S., Prostaglandins and the gastrointestinal mucosa: are they important in in its function, disease or treatment?Gastroenterology, 89, 1162–1188 (1985).
Isdale, A. and Wright, V., Misoprostol/NSAID fixed combinations: Help or hindrance in clinical practice?Drug Safety, 12, 291–298 (1995).
Kastrup, E. K.,Facts and Comparison. Lippincott, J. B., St. Louis, 1983.
Katz, L. B., Capetola, R. J., Argentieri, D. C., Moore, L. E., Genna, T., Porter, M. C., Jasty, V., Hartnagel, R. E., Abrutyn, D. and Shriver, D. A., Rioprostil prevents gastric bleeding induced by nonsteroidal antiinflammatory drugs in dogs and arthritic rats.J. Rheumatol., 13, 887–894 (1986).
Kim, O.-J., Kang, K.-K., Kim, D.-H., Baik, N.-G., Ahn, B.-O., Kim, W.-B. and Yang, J., Four-week oral toxicity study of DA-9601, an antiulcer agent of Artemisia spp. extract, in rats.J. Appl. Pharmacol., 4, 354–363 (1996).
Kitahora, T. and Guth, P. H., Effect of aspirin plus hydrochloric acid on the gastric mucosal microcirculation.Gastroenterology, 93, 810–817 (1987).
Lee, E.-B., Cheon, S.-A., Lee, E.-S., Kim O.-K., Ko, S.-T., Yu, K.-J., Shin, D.-S., Kang, S.-Y., Kim, S.-H. and Sohn, M.-H., General pharmacology of Artemisia extract powder, DA-9601.J. Appl. Pharmacol. 4, 174–183 (1996).
Lipscomb, G. R. and Rees, W. D. W., Gastric mucosal injury and adaptation to oral and rectal administration of naproxen.Aliment. Pharmacol. Therm., 10, 133–138 (1996).
McCafferty, D.-M., Granger, D. N. and Wallace, J. L., Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats.Gastroenterology, 109, 1173–1180 (1995).
Oh, T.-Y., Ryu, B.-K., Park, J.-B., Lee, S.-D., Kim, W.-B., Y. J. and Lee, E.-B., Studies on antiulcer effects of DA-9601, an Artemisiae Herba extract against experimental gastric ulcers and its mechanism.J. Appl. Pharmacol., 4, 111–121 (1996).
Oh, T.-Y., Ahn B.-O., Ko, J.-I., Ryu, B.-K. Son, M.-W., Kim, S.-H., Kim, W.-B. and Lee, E.-B., Studies on protective effect of DA-9601, an Artemisiae Herba extract, against ethanol-induced gastric mucosal damage and its mechanism.J. Appl. Pharmacol., 5, 202–210 (1997).
Rainsford, K. D., Mechanisms of gastrointestinal damage by NSAIDs.Agents Actions, 44, 59–64 (1993).
Roth, S. H. and Bennett, R. E., Nonsteroidal anti-inflammatory drugs gastropathy. Recognition and response.Arch. Intern. Med., 147, 2093–2100 (1987).
Schoen, R. T. and Vender, R. J., Mechanisms of non-steroidal anti-inflammatory drug-induced gastric damage.Am. J. Med., 86, 449–458 (1989).
Simon, L. S. and Mills, J. A., Drug therapy: nonsteroidal antiinflammatory drugs.New Engl. J. Med., 302, 1179–1185 (1980).
Soll, A. H., Weinstein, W. M., Kurata, J. and McCarthy, D., Nonsteroidal anti-inflammatory drugs and peptic ulcer disease.Ann. Intern. Med., 114, 307–319 (1991).
Wallace, J. L., Gastric ulceration: critical events at the neutrophil-endothelium interface.Can. J. Physiol. Pharmacol., 71, 98–102 (1993).
Yang, J., DA-9601, antiulcer agent, Final report of Good Health R&D Program, Ministry of Health and Welfare, Republic of Korea, 1995.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Oh, T.Y., Ryu, B.K., Ko, J.I. et al. Protective effect of DA-9601, an extract ofArtemisiae Herba, against naproxen-induced gastric damage in arthritic rats. Arch. Pharm. Res. 20, 414–419 (1997). https://doi.org/10.1007/BF02973932
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02973932